STAGE I BLADDER CANCER AJCC V8
Clinical trials for STAGE I BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE I BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE I BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to fight tough bladder cancer
Disease control OngoingThis phase II trial is testing whether adding the immunotherapy drug pembrolizumab to the chemotherapy drug gemcitabine can help patients with a type of bladder cancer that does not respond to the usual BCG treatment. The study involves 161 participants and looks at how many pati…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New vaccine combo aims to train immune system to fight bladder cancer
Disease control OngoingThis early-stage trial is testing a new peptide vaccine (IO102-IO103) combined with the immunotherapy drug pembrolizumab (Keytruda) in 30 adults with high-risk non-muscle invasive bladder cancer that did not respond to or could not tolerate standard BCG therapy. The vaccine is de…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Bladder cancer survivors share how treatment changes their daily lives
Knowledge-focused OngoingThis study follows 204 people with bladder cancer to see how their quality of life changes after treatment like surgery or radiation. Participants fill out surveys about physical function, pain, fatigue, anxiety, and bladder, bowel, and sexual health. The goal is to understand ho…
Matched conditions: STAGE I BLADDER CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC